Inventor
ZHAO XINGDONG
CN23 patents
⚠️ This page may combine multiple inventors who share the name “ZHAO XINGDONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SHANGHAI FOCHON PHARMACEUTICAL CO LTD
12 patentsUS9714235B2Jul 25, 2017
Quinazoline derivatives, compositions thereof, and use as pharmaceuticals
SHANGHAI FOCHON PHARMACEUTICAL CO LTD3 citations71
US9556171B2Jan 31, 2017
Certain protein kinase inhibitors
SHANGHAI FOCHON PHARMACEUTICAL CO LTD2 citations70
US9206166B2Dec 8, 2015
Certain protein kinase inhibitors
SHANGHAI FOCHON PHARMACEUTICAL CO LTD2 citations61
US10087195B2Oct 2, 2018
Certain protein kinase inhibitors
SHANGHAI FOCHON PHARMACEUTICAL CO LTD2 citations60
US9567342B2Feb 14, 2017
Certain protein kinase inhibitors
SHANGHAI FOCHON PHARMACEUTICAL CO LTD0 citations51
US11168078B2Nov 9, 2021
Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenase
SHANGHAI FOCHON PHARMACEUTICAL CO LTD0 citations50
US10053449B2Aug 21, 2018
Quinazoline derivatives, compositions thereof, and use as pharmaceuticals
SHANGHAI FOCHON PHARMACEUTICAL CO LTD0 citations50
US10894038B2Jan 19, 2021
Indolizine derivatives, composition and methods of use
SHANGHAI FOCHON PHARMACEUTICAL CO LTD0 citations49
US10022374B2Jul 17, 2018
Certain protein kinase inhibitors
SHANGHAI FOCHON PHARMACEUTICAL CO LTD0 citations49
US10835535B2Nov 17, 2020
Certain protein kinase inhibitors
SHANGHAI FOCHON PHARMACEUTICAL CO LTD0 citations40
US10800785B2Oct 13, 2020
Substituted pyrrolo[2,3-d]pyridazin-4-ones and pyrazolo[3,4-d]pyridazin-4-ones as protein kinase inhibitors
SHANGHAI FOCHON PHARMACEUTICAL CO LTD0 citations39
US10328060B2Jun 25, 2019
Certain protein kinase inhibitors
SHANGHAI FOCHON PHARMACEUTICAL CO LTD0 citations38
FOCHON PHARMACEUTICALS LTD
4 patentsUS11053239B2Jul 6, 2021
Compounds as BLC-2-selective apoptosis-inducing agents
FOCHON PHARMACEUTICALS LTD6 citations70
US11091478B2Aug 17, 2021
Apoptosis-inducing agents
FOCHON PHARMACEUTICALS LTD2 citations68
US11485707B2Nov 1, 2022
Deuterated compounds as rock inhibitors
FOCHON PHARMACEUTICALS LTD0 citations59
US12312349B2May 27, 2025
Apoptosis-inducing agents
FOCHON PHARMACEUTICALS LTD0 citations58